Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims

Background The bias implications of outcome misclassification arising from imperfect capture of mortality in claims‐based studies are not well understood. Methods and Results We identified 2 cohorts of patients: (1) type 2 diabetes mellitus (n=8.6 million), and (2) heart failure (n=3.1 million), fro...

Full description

Bibliographic Details
Main Authors: Rishi J. Desai, Raisa Levin, Kueiyu Joshua Lin, Elisabetta Patorno
Format: Article
Language:English
Published: Wiley 2020-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.016906
_version_ 1797607615938691072
author Rishi J. Desai
Raisa Levin
Kueiyu Joshua Lin
Elisabetta Patorno
author_facet Rishi J. Desai
Raisa Levin
Kueiyu Joshua Lin
Elisabetta Patorno
author_sort Rishi J. Desai
collection DOAJ
description Background The bias implications of outcome misclassification arising from imperfect capture of mortality in claims‐based studies are not well understood. Methods and Results We identified 2 cohorts of patients: (1) type 2 diabetes mellitus (n=8.6 million), and (2) heart failure (n=3.1 million), from Medicare claims (2012–2016). Within the 2 cohorts, mortality was identified from claims using the following approaches: (1) all‐place all‐cause mortality, (2) in‐hospital all‐cause mortality, (3) all‐place cardiovascular mortality (based on diagnosis codes for a major cardiovascular event within 30 days of death date), or (4) in‐hospital cardiovascular mortality, and compared against National Death Index identified mortality. Empirically identified sensitivity and specificity based on observed values in the 2 cohorts were used to conduct Monte Carlo simulations for treatment effect estimation under differential and nondifferential misclassification scenarios. From National Death Index, 1 544 805 deaths (549 996 [35.6%] cardiovascular deaths) in the type 2 diabetes mellitus cohort and 1 175 202 deaths (523 430 [44.5%] cardiovascular deaths) in the heart failure cohort were included. Sensitivity was 99.997% and 99.207% for the all‐place all‐cause mortality approach, whereas it was 27.71% and 33.71% for the in‐hospital all‐cause mortality approach in the type 2 diabetes mellitus and heart failure cohorts, respectively, with perfect positive predicted values. For all‐place cardiovascular mortality, sensitivity was 52.01% in the type 2 diabetes mellitus cohort and 53.83% in the heart failure cohort with positive predicted values of 49.98% and 54.45%, respectively. Simulations suggested a possibility for substantial bias in treatment effects. Conclusions Approaches to identify mortality from claims had variable performance compared with the National Death Index. Investigators should anticipate the potential for bias from outcome misclassification when using administrative claims to capture mortality.
first_indexed 2024-03-11T05:32:21Z
format Article
id doaj.art-f652e2b107ec4a77a2d8daca6deae520
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-03-11T05:32:21Z
publishDate 2020-09-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-f652e2b107ec4a77a2d8daca6deae5202023-11-17T17:02:37ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-09-0191710.1161/JAHA.120.016906Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative ClaimsRishi J. Desai0Raisa Levin1Kueiyu Joshua Lin2Elisabetta Patorno3Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women’s Hospital & Harvard Medical School Boston MADivision of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women’s Hospital & Harvard Medical School Boston MADivision of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women’s Hospital & Harvard Medical School Boston MADivision of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women’s Hospital & Harvard Medical School Boston MABackground The bias implications of outcome misclassification arising from imperfect capture of mortality in claims‐based studies are not well understood. Methods and Results We identified 2 cohorts of patients: (1) type 2 diabetes mellitus (n=8.6 million), and (2) heart failure (n=3.1 million), from Medicare claims (2012–2016). Within the 2 cohorts, mortality was identified from claims using the following approaches: (1) all‐place all‐cause mortality, (2) in‐hospital all‐cause mortality, (3) all‐place cardiovascular mortality (based on diagnosis codes for a major cardiovascular event within 30 days of death date), or (4) in‐hospital cardiovascular mortality, and compared against National Death Index identified mortality. Empirically identified sensitivity and specificity based on observed values in the 2 cohorts were used to conduct Monte Carlo simulations for treatment effect estimation under differential and nondifferential misclassification scenarios. From National Death Index, 1 544 805 deaths (549 996 [35.6%] cardiovascular deaths) in the type 2 diabetes mellitus cohort and 1 175 202 deaths (523 430 [44.5%] cardiovascular deaths) in the heart failure cohort were included. Sensitivity was 99.997% and 99.207% for the all‐place all‐cause mortality approach, whereas it was 27.71% and 33.71% for the in‐hospital all‐cause mortality approach in the type 2 diabetes mellitus and heart failure cohorts, respectively, with perfect positive predicted values. For all‐place cardiovascular mortality, sensitivity was 52.01% in the type 2 diabetes mellitus cohort and 53.83% in the heart failure cohort with positive predicted values of 49.98% and 54.45%, respectively. Simulations suggested a possibility for substantial bias in treatment effects. Conclusions Approaches to identify mortality from claims had variable performance compared with the National Death Index. Investigators should anticipate the potential for bias from outcome misclassification when using administrative claims to capture mortality.https://www.ahajournals.org/doi/10.1161/JAHA.120.016906biasmortalityobservational studiesoutcome misclassification
spellingShingle Rishi J. Desai
Raisa Levin
Kueiyu Joshua Lin
Elisabetta Patorno
Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
bias
mortality
observational studies
outcome misclassification
title Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
title_full Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
title_fullStr Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
title_full_unstemmed Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
title_short Bias Implications of Outcome Misclassification in Observational Studies Evaluating Association Between Treatments and All‐Cause or Cardiovascular Mortality Using Administrative Claims
title_sort bias implications of outcome misclassification in observational studies evaluating association between treatments and all cause or cardiovascular mortality using administrative claims
topic bias
mortality
observational studies
outcome misclassification
url https://www.ahajournals.org/doi/10.1161/JAHA.120.016906
work_keys_str_mv AT rishijdesai biasimplicationsofoutcomemisclassificationinobservationalstudiesevaluatingassociationbetweentreatmentsandallcauseorcardiovascularmortalityusingadministrativeclaims
AT raisalevin biasimplicationsofoutcomemisclassificationinobservationalstudiesevaluatingassociationbetweentreatmentsandallcauseorcardiovascularmortalityusingadministrativeclaims
AT kueiyujoshualin biasimplicationsofoutcomemisclassificationinobservationalstudiesevaluatingassociationbetweentreatmentsandallcauseorcardiovascularmortalityusingadministrativeclaims
AT elisabettapatorno biasimplicationsofoutcomemisclassificationinobservationalstudiesevaluatingassociationbetweentreatmentsandallcauseorcardiovascularmortalityusingadministrativeclaims